Search research articles
Contact Us
Filters
Showing results (241-250 of 259) with videos related to
Page
of 26
Sort By:
Clinical Colorectal Cancer
|
June 5, 2019
The Prevalence of DPYD*9A(c.85T>C) Genotype and the Genotype-Phenotype Correlation in Patients with Gastrointestinal Malignancies Treated With Fluoropyrimidines: Updated Analysis
Anu Singh Maharjan, Gwendolyn A McMillin, Girijesh Kumar Patel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 23, 2012
Diphtheria toxin-epidermal growth factor fusion protein DAB389EGF for the treatment of bladder cancer
Xiaoping Yang, Elizabeth Kessler, Lih-Jen Su, et al.
Nature Communications
|
September 30, 2016
Erratum: Synergistic effects of ion transporter and MAP kinase pathway inhibitors in melanoma
Ugur Eskiocak, Vijayashree Ramesh, Jennifer G Gill, et al.
Leukemia
|
April 14, 2000
Diphtheria toxin fused to human interleukin-3 is toxic to blasts from patients with myeloid leukemias
A E Frankel, J A McCubrey, M S Miller, et al.
The Journal of Biological Chemistry
|
November 3, 2007
Matrix metalloproteinase-activated anthrax lethal toxin demonstrates high potency in targeting tumor vasculature
Shihui Liu, Hailun Wang, Brooke M Currie, et al.
Blood Advances
|
October 7, 2020
Blastic plasmacytoid dendritic cell neoplasms: results of an international survey on 398 adult patients
Kamel Laribi, Alix Baugier de Materre, Mohamad Sobh, et al.
Translational Oncology
|
October 27, 2015
Phospho-MEK1/2 and uPAR Expression Determine Sensitivity of AML Blasts to a Urokinase-Activated Anthrax Lethal Toxin (PrAgU2/LF)
Amira Bekdash, Manal Darwish, Zahra Timsah, et al.
Human Molecular Genetics
|
September 12, 2015
Human recombinant arginase enzyme reduces plasma arginine in mouse models of arginase deficiency
Lindsay C Burrage, Qin Sun, Sarah H Elsea, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 15, 2015
Phase I study of a bispecific ligand-directed toxin targeting CD22 and CD19 (DT2219) for refractory B-cell malignancies
Veronika Bachanova, Arthur E Frankel, Qing Cao, et al.
Angiogenesis
|
February 25, 2022
Capillary morphogenesis gene 2 (CMG2) mediates growth factor-induced angiogenesis by regulating endothelial cell chemotaxis
Lorna M Cryan, Tsz-Ming Tsang, Jessica Stiles, et al.
Page
of 26
Search research articles
Search
Showing results (241-250 of 259) with videos related to
Sort By:
Page
of 26
Clinical Colorectal Cancer
|
June 5, 2019
The Prevalence of DPYD*9A(c.85T>C) Genotype and the Genotype-Phenotype Correlation in Patients with Gastrointestinal Malignancies Treated With Fluoropyrimidines: Updated Analysis
Anu Singh Maharjan, Gwendolyn A McMillin, Girijesh Kumar Patel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 23, 2012
Diphtheria toxin-epidermal growth factor fusion protein DAB389EGF for the treatment of bladder cancer
Xiaoping Yang, Elizabeth Kessler, Lih-Jen Su, et al.
Nature Communications
|
September 30, 2016
Erratum: Synergistic effects of ion transporter and MAP kinase pathway inhibitors in melanoma
Ugur Eskiocak, Vijayashree Ramesh, Jennifer G Gill, et al.
Leukemia
|
April 14, 2000
Diphtheria toxin fused to human interleukin-3 is toxic to blasts from patients with myeloid leukemias
A E Frankel, J A McCubrey, M S Miller, et al.
The Journal of Biological Chemistry
|
November 3, 2007
Matrix metalloproteinase-activated anthrax lethal toxin demonstrates high potency in targeting tumor vasculature
Shihui Liu, Hailun Wang, Brooke M Currie, et al.
Blood Advances
|
October 7, 2020
Blastic plasmacytoid dendritic cell neoplasms: results of an international survey on 398 adult patients
Kamel Laribi, Alix Baugier de Materre, Mohamad Sobh, et al.
Translational Oncology
|
October 27, 2015
Phospho-MEK1/2 and uPAR Expression Determine Sensitivity of AML Blasts to a Urokinase-Activated Anthrax Lethal Toxin (PrAgU2/LF)
Amira Bekdash, Manal Darwish, Zahra Timsah, et al.
Human Molecular Genetics
|
September 12, 2015
Human recombinant arginase enzyme reduces plasma arginine in mouse models of arginase deficiency
Lindsay C Burrage, Qin Sun, Sarah H Elsea, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 15, 2015
Phase I study of a bispecific ligand-directed toxin targeting CD22 and CD19 (DT2219) for refractory B-cell malignancies
Veronika Bachanova, Arthur E Frankel, Qing Cao, et al.
Angiogenesis
|
February 25, 2022
Capillary morphogenesis gene 2 (CMG2) mediates growth factor-induced angiogenesis by regulating endothelial cell chemotaxis
Lorna M Cryan, Tsz-Ming Tsang, Jessica Stiles, et al.
Page
of 26